Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study was to evaluate 4000 subjects with acute coronary syndrome
by comparing pravastatin 40 mg to atorvastatin 80 mg to determine if they are clinically
equivalent, and to evaluate the effectiveness of gatifloxacin therapy in reducing
cardiovascular events in combination with statin therapy.